Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Björkholm

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Clinical Lymphoma|January 8, 2005
Treatment options in Waldenstrom's macroglobulinemiaMagnus Björkholm
European Journal of Haematology|July 22, 2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?Honar Cherif, Mats Kalin, Magnus Björkholm
Current Opinion in Oncology|June 18, 2011
How we treat elderly patients with Hodgkin lymphomaMagnus Björkholm, Erik Svedmyr, Jan Sjöberg
Haematologica|August 2, 2014
Cancer survivorship programs: time for concerted actionTiziano Barbui, Magnus Björkholm, Alois Gratwohl
Best Practice & Research. Clinical Haematology|September 6, 2014
Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?Magnus Björkholm, Malin Hultcrantz, Åsa Rangert Derolf
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemiaSigurdur Y Kristinsson, Magnus Björkholm, Ola Landgren
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisHonar Cherif, Göran Kronvall, Magnus Björkholm, et al.
Clinical Drug Investigation|May 14, 2014
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in SwedenJohan Lundberg, Martin Höglund, Magnus Björkholm, et al.
European Journal of Epidemiology|September 20, 2005
Sick leave due to depressive disease: not a risk factor for the development of malignant lymphomaMarie Nordström, Fredrik Granath, Magnus Björkholm, et al.
Haematologica|February 8, 2006
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignanciesHonar Cherif, Eva Johansson, Magnus Björkholm, et al.
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Clinical Lymphoma|January 8, 2005
Treatment options in Waldenstrom's macroglobulinemiaMagnus Björkholm
European Journal of Haematology|July 22, 2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?Honar Cherif, Mats Kalin, Magnus Björkholm
Current Opinion in Oncology|June 18, 2011
How we treat elderly patients with Hodgkin lymphomaMagnus Björkholm, Erik Svedmyr, Jan Sjöberg
Haematologica|August 2, 2014
Cancer survivorship programs: time for concerted actionTiziano Barbui, Magnus Björkholm, Alois Gratwohl
Best Practice & Research. Clinical Haematology|September 6, 2014
Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?Magnus Björkholm, Malin Hultcrantz, Åsa Rangert Derolf
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemiaSigurdur Y Kristinsson, Magnus Björkholm, Ola Landgren
The Hematology Journal : the Official Journal of the European Haematology Association|December 13, 2003
Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisHonar Cherif, Göran Kronvall, Magnus Björkholm, et al.
Clinical Drug Investigation|May 14, 2014
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in SwedenJohan Lundberg, Martin Höglund, Magnus Björkholm, et al.
European Journal of Epidemiology|September 20, 2005
Sick leave due to depressive disease: not a risk factor for the development of malignant lymphomaMarie Nordström, Fredrik Granath, Magnus Björkholm, et al.
Haematologica|February 8, 2006
The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignanciesHonar Cherif, Eva Johansson, Magnus Björkholm, et al.
Pageof 22